Our efforts to test an association of germline TLR9 variants with AA breast cancer risk did not reveal any variant class differences between cases and controls; however, three previously unreported TLR9 variants appears to be slightly associated with late (>45 years) onset breast cancer. Here, TLR9 is linked to breast carcinoma.